Iran J Vet Surg, Print ISSN: 2008-3033, Online ISSN: 2676-6299

Document Type : Clinical Report


1 Department of Internal Medicine and Clinical Pathology, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.

2 Department of Surgery and Diagnostic Imaging, Faculty of Veterinary Medicine, Urmia University, Urmia, Iran.


We report an 11-year-old Kurdish gelding with an anaplastic malignant melanoma arising from his right lateral of the neck, which developed over 6 weeks. A ~10 cm in diameter, firm, and non-ulcerated nodular subcutaneous mass located at the middle and proximal of the left side of the neck was detected in a physical examination. No evidence of local extent or metastasis was detected. Complete surgical excision was performed under general anesthesia. Gross morphology and histopathological examination of the mass confirmed an anaplastic malignant melanoma, in which the major part of the mass has little or no pigmentation. The gelding was euthanized due to tumor regrowth. The heterogeneity in pigmentation of equine melanocytic tumors can make diagnosis difficult in punch biopsy specimens. Anaplastic malignant melanoma is most often a very aggressive neoplasm and surgical excision was not effective in this case.


Main Subjects

  1. Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between condition score, physical measurements and body fat percentage in mares. Equine Veterinary Journal. 1983;15(4):371-372.
  2. Phillips JC. Lembcke LM. Equine melanocytic tumors. Veterinary Clinics: Equine Practice. 2013;29(3):673-687.
  3. MacKay RJ. Treatment options for melanoma of gray Horses. Veterinary Clinics: Equine Practice. 2019;35(2):311-325.
  4. Groom L. Sullins K. Surgical excision of large melanocytic tumours in grey horses: 38 cases (2001–2013). Equine Veterinary Education. 2018. 30(8):438-443.
  5. Seltenhammer MH, Heere‐Ress E, Brandt S, Druml T, Jansen B, Pehamberger H, Niebauer GW. Comparative histopathology of grey‐horse‐melanoma and human malignant melanoma. Pigment Cell Research. 2004;17(6):674-681.
  6. Valentine BA, Equine melanocytic tumors: a retrospective study of 53 horses (1988 to 1991). Journal of Veterinary Internal Medicine. 1995;9(5):291-297.
  7. Smith S. Goldschmidt M. McManus P. A comparative review of melanocytic neoplasms. Veterinary Pathology. 2002;39(6):651-678.
  8. Scott DW. Miller WH. Equine Dermatology-E-Book. 2010: Elsevier Health Sciences.
  9. MacGillivray KC. Sweeney RW. Piero FD. Metastatic melanoma in horses. Journal of Veterinary Internal Medicine. 2002;16(4):452-456.
  10. Reed SM. Bayly WM. Sellon DC. Equine Internal Medicine-E-Book. 2017: Elsevier Health Sciences.
  11. Ramos-Vara JA, Frank CB, DuSold D, Miller MA. Immunohistochemical expression of melanocytic antigen PNL2, Melan A, S100, and PGP 9.5 in equine melanocytic neoplasms. Veterinary Pathology. 2014;51(1):161-166.
  12. Goldschmidt MH. Goldschmidt KH. Epithelial and melanocytic tumors of the skin. Tumors in Domestic Animals. 2016;5:129-131.
  13. Valentine B. Calderwood Mays M. Cheramie H. Anaplastic malignant melanoma of the tail in non‐grey horses. Equine Veterinary Education. 2014;26(3):156-158.
  14. Tyler R. Fox R. Nasopharyngeal malignant amelanotic melanoma in a gelding age 9 years. Equine Veterinary Education. 2003;15(1):19-26.
  15. Koch SE. Lange JR. Amelanotic melanoma: the great masquerader. Journal of the American Academy of Dermatology. 2000;42(5):731-734.